Neurocrine Biosciences





Ebitda Cambiamento Data
AbbVie USD 4.34B 56M 2025-06
Acadia Pharmaceuticals USD 35.76M 447K 2025-09
Agios Pharmaceuticals USD -125.8M 20.45M 2025-06
ALKERMES USD 121.55M 4.99M 2025-09
Alnylam Pharmaceuticals USD 381.78M 362.95M 2025-09
Amgen USD 5.91B 2.31B 2025-09
Biogen USD 1.01B 456.5M 2025-06
BioMarin Pharmaceutical USD 295.45M 49.49M 2025-06
Cytokinetics USD -107.82M 45.51M 2025-06
Dynavax Technologies USD 35.53M 10.9M 2025-09
Exelixis USD 248.93M 28.02M 2025-09
Gilead Sciences USD 4.03B 628M 2025-09
Halozyme Therapeutics USD 248.25M 22.74M 2025-09
Incyte USD 581.52M 358.87M 2025-06
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
Neurocrine Biosciences USD 246.7M 93.8M 2025-09
Pfizer USD 6.08B 351M 2025-09
Prothena USD -39.53M 12.25M 2025-09
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Repligen USD 35.93M 3.75M 2025-09
Sarepta Therapeutics USD 126.42M 416.82M 2025-06
Teva Pharmaceutical Industries USD 1.64B 243M 2025-12
Ultragenyx Pharmaceutical USD -91.34M 35.09M 2025-06
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09


Neurocrine Biosciences - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.